Clinical Trial Search

Primary: Change in Walking Speed During Single and Dual-task Walking Conditions — -3.33; -0.53; 5.89; -10.55 centimeters per second

Primary: Change in Right Insula-dorsomedial Frontal Cortex Functional Connectivity Strength. — 93.2; 97.8 percent change from baseline — p=0.981

Primary: MEP Amplitude — 0.813; 0.475; 0.916; 1.237 mV — p=>0.00238

Primary: Peak Activity Volume: Right D1 Attempt Movement Activity at S1 - SCI — 893.6 mm^3

Primary: Kinematic Analysis: Change in Hip Flexion During Initial Contact. Baseline and 12 Weeks — -1.33; 5.1; 1.53 degrees

Primary: Prefrontal Cortical Activity — 0.04; 0.11; 0.58; -0.62 μM

Primary: Serial Reaction Time Task (SRTT) Performance — 31; 35; 38; 24 milliseconds (ms)

Primary: Resting-state PMv-M1 Functional Connectivity (Fisher Z-transformed Correlation) — 0.64 unitless (Fisher z-score)

Primary: Changes in Cortical Excitability and Cortical Activation Patterns as Measured by MRI and Functional MRI — 0.71; 0.72; -0.25; 0.81 Laterality index

Primary: Change in Overt Tapping Accuracy as Assessed by Finger Tapping to a Flashing Cue at 1Hz Speed — .00141488 taps per second

Primary: Upper Extremity Component of Fugl-Meyer Assessment — 35.3; 32.6; 0.9; 0.8 units on a scale

Primary: Arm Motor Abilities Test Functional Domain (AMAT - F) — .54 units on a scale

Primary: Gray Matter Volume Biomarkers of 6 Month Prognosis as Measured by Voxel Based Morphometry - Within Group Comparison — 4.18; 3.27; 3.85; 3.76 peak voxel z-score

Primary: Changes in Motor-evoked Potentials Ratios — 1.32; 0.73; 1.03 Ratio (unit: uV)

Primary: Percentage Change in the Time to Complete the Nine-hole Peg Test (9-HPT) to Immediate Post-intervention — 7.37; -0.15; -4.68 Percentage change in 9HPT time

Primary: Motor Skill — 66.6; 59.4; 59.9; 64.9 Accuracy (%) — p=0.55

Primary: Changes in Brain Activation — 48.5; -30 voxels

Primary: BCI Performance Change From Baseline — 16.87; 7.9 Percent valid correct (PVC) — p=0.003

Primary: Change From Baseline in Sequential Response Time to Post-Intervention — 8.68; 8.84; 8.32; 7.96 seconds

Primary: Number of Participants With Patient Control Over the End Effector (Virtual or Physical) — 1 Participants

Primary: Change From Baseline in Fugl-Meyer Arm (FMA) Motor Score — 37.8; 41.3; 47; 41.3 score on a scale

Primary: Physiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS — 0.31; 0.43; 0.45; 0.65 millivolts (mV)

Primary: Percentage BOLD (Blood-oxygen-level Dependent Contrast Imaging) Signal From Baseline at 2 Weeks — 3; 2 percentage change of BOLD

Primary: Fugl-Meyer Test of Motor Function — 1.9; .8; 1.3; .8 units on a scale

Primary: The Gross Motor Function Measure (GMFM-66) Score at Entry, the Second and the Sixth Month. — 44.8; 49.4; 54.7; 57.5 Scores on a scale — p=0.34

Primary: Change in Action Research Arm Test (ARAT) Score — 6.2 units on a scale — p=0.002

Primary: Change in Primary Motor Cortex Beta-Band Spectral Power During Movement Preparation With Anodal tDCS — 12 log10(µV²/Hz)

Primary: Extent of Tumor Resection — 40; 7; 7; 4 participants

Primary: Fugl-Meyer Assessment - Upper Extremity — 9.18 Units on a scale

Primary: Correlation Coefficient Between UPDRS III Score and Independent Components Analysis Network Strength in Left Parietal Cortex. — 0.5869 unitless